Hemianopsia Rehabilitation After Stroke or Brain Injury
Launched by UNIVERSITY OF ALBERTA · Jan 26, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help people who have lost part of their vision, called hemianopsia, after experiencing a stroke or brain injury. The researchers want to see if showing images through a PowerPoint presentation can stimulate and improve their visual field. If you or a loved one has this condition and is between the ages of 18 and older, you might be eligible to participate, as long as you can understand and communicate in English and do not have a history of seizures triggered by flashing lights.
As a participant in this study, you can expect to undergo a series of visual exercises that involve looking at different images. The goal is to see if this method can help expand your vision and improve your daily activities. It's important to note that individuals who have light-induced seizures cannot join the trial due to safety concerns. This study is currently recruiting participants, and your involvement could contribute to important advancements in rehabilitation for visual impairments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients 18 years of age or older with a homonymous hemianopsia or quadrantopsia, who can provide informed consent, and communicate in English.
- Exclusion Criteria:
- • The flashing lights from thge automated perimeter and PowerPoint program can potentially trigger photic seizures. Therefore patients with light-induced seizures are excluded.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported